The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

  1. Rouhi, L.
  2. Fan, S.
  3. Cheedipudi, S.M.
  4. Braza-Boïls, A.
  5. Molina, M.S.
  6. Yao, Y.
  7. Robertson, M.J.
  8. Coarfa, C.
  9. Gimeno, J.R.
  10. Molina, P.
  11. Gurha, P.
  12. Zorio, E.
  13. Marian, A.J.
Aldizkaria:
Cardiovascular research

ISSN: 1755-3245

Argitalpen urtea: 2022

Alea: 118

Zenbakia: 6

Orrialdeak: 1466-1478

Mota: Artikulua

DOI: 10.1093/CVR/CVAB197 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus